The estimated Net Worth of Rick D Anderson is at least $12.7 Million dollars as of 5 September 2017. Mr. Anderson owns over 176,000 units of Apollo Endosurgery Inc stock worth over $12,669,090 and over the last 10 years he sold APEN stock worth over $0. In addition, he makes $0 as Independent Director at Apollo Endosurgery Inc.
Rick has made over 2 trades of the Apollo Endosurgery Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 176,000 units of APEN stock worth $684,640 on 5 September 2017.
The largest trade he's ever made was buying 1,136,363 units of Apollo Endosurgery Inc stock on 25 July 2017 worth over $6,249,997. On average, Rick trades about 87,491 units every 3 days since 2014. As of 5 September 2017 he still owns at least 1,266,909 units of Apollo Endosurgery Inc stock.
You can see the complete history of Mr. Anderson stock trades at the bottom of the page.
Rick D. Anderson serves as Independent Director of the Company. Since October 2013, Mr. Anderson has served as a member of our Board. Since January 2018, Mr. Anderson has served as the Chairman of Revival Healthcare Capital, a private investment firm. From 2008 to January 2018, Mr. Anderson served as a Managing Director at PTV Healthcare Capital, a venture capital and private equity firm specializing in the healthcare and life sciences industries. Since 2008, Mr. Anderson has served as the Chairman of the Board of Directors for Cardiva Medical, Inc., a privately held medical device company. From September 2018 to October 2019, Mr. Anderson served as CEO and Chairman of the Board of Directors of ConvaTec Group Plc, a publicly traded medical products and technologies company. From 2008 to December 2014, Mr. Anderson served as a director of Intersect ENT, Inc., a publicly traded medical device company. Mr. Anderson holds a B.B.A. in Marketing from Mississippi State University.
Rick Anderson is 59, he's been the Independent Director of Apollo Endosurgery Inc since 2013. There are 8 older and 10 younger executives at Apollo Endosurgery Inc. The oldest executive at Apollo Endosurgery Inc is Dr. Christopher J. Gostout, 70, who is the Co-Founder & Chief Medical Officer.
Rick's mailing address filed with the SEC is 3600 N Capital of Texas Hwy b180, Austin, TX 78746, USA.
Over the last 12 years, insiders at Apollo Endosurgery Inc have traded over $3,882,241 worth of Apollo Endosurgery Inc stock and bought 10,717,094 units worth $45,588,363 . The most active insiders traders include Holdings A/S Novo, Neil Gagnon, and R Kent Jr Mc Gaughy. On average, Apollo Endosurgery Inc executives and independent directors trade stock every 41 days with the average trade being worth of $2,726,880. The most recent stock trade was executed by Jeffrey G. Black on 25 February 2022, trading 40,000 units of APEN stock currently worth $229,200.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo Endosurgery Inc executives and other stock owners filed with the SEC include: